Bruyere Research Institute
Ottawa, Ontario, Canada
NCT Number: NCT03048409
A retrospective chart review to assess feeding tolerance in adults who had been switched from an intact protein formula to a peptide-based formula due to feeding intolerance in a complex continuing care facility.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Ottawa, Ontario, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Enteral feeding with a peptide-based formula.
Time frame: Up to 30 days after formula switch
no change, tolerance improved, tolerance worsened
Time frame: Up to 30 days after formula switch
no change, tolerance improved, tolerance worsened
Time frame: Up to 30 days after formula switch
no change, tolerance improved, tolerance worsened
Time frame: Up to 30 days after formula switch
no change, tolerance improved, tolerance worsened
Time frame: Up to 30 days after formula switch
too hard, too loose
Time frame: Up to 30 days after formula switch
documentation of feeding volume after switch as "less than," "about the same as," or "more than" feeding volume achieved before switch
Time frame: Up to 30 days after formula switch
Number of tube feeding interruptions
Time frame: Prior to and up to 30 days following formula switch.
Measured body weight
Time frame: Prior to and up to 30 days following formula switch.
Documented medication use
Time frame: Up to 30 days after formula switch
Measured daily calorie intake
Time frame: Up to 30 days after formula switch
Measured daily protein intake
Société des Produits Nestlé (SPN)
Industry
Acronym: RAP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04337710
Enteral Feeding Intolerance, Female Urogenital Diseases and Pregnancy Complications
Birmingham, Alabama, United States
View Trial DetailsNCT05265143
Enteral Feeding Intolerance, Female Urogenital Diseases and Pregnancy Complications
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03795870
Enteral Feeding Intolerance
Rochester, Minnesota, United States
View Trial DetailsNCT03422900
Brain Diseases, Cardiovascular Diseases
Valladolid, Spain
View Trial Details